CD44 and acute kidney injury: Our findings indicate that treatment with L929-MVs or MSC-MVs in AKI mice resulted in a significant increase in cytoprotective CD4+ CD25+FOXP3+ T cells in the spleen (Figure 5) as well as a decrease in cytodestructive CD4+ CD44+ CD62L+ T cells (Figure 6).